Target intelligence / Profile preview

Schwann cell repair phenotype

Molecular classification
Other (cell phenotype; not a single molecular entity)
01

Overview

Repair Schwann cells are a specialized, transient cell phenotype that arises when mature Schwann cells undergo reprogramming in response to nerve injury. This phenotype is characterized by the de-differentiation and upregulation of regenerative programs, including secretion of neurotrophic and growth factors (GDNF, BDNF, NGF, NT-3, VEGF), recruitment of macrophages via cytokine signaling, activation of autophagy for myelin clearance, and formation of guiding tracks (bands of Büngner) to support axonal regrowth. These repair cells are essential for successful peripheral nerve regeneration, but their regenerative capacity diminishes in chronic denervation or aging, often due to reduced expression of key regulators such as c-Jun. The “Schwann cell-like neuronal regeneration-promoting activity” therefore reflects a multifactorial, cell-based process rather than a classical molecular target[1][2][3][4][5][7].

Other names
Repair Schwann cellBungner Schwann cellSchwann cell pro-regenerative phenotype
02

Mechanism of action

Enhancement of neurotrophic factor expression; Promotion of c-Jun pathway signaling; Facilitation of autophagy and myelin clearance; Support of axonal guidance and scaffold formation

03

Biological functions

Promotion of axonal regrowthRemyelinationNeuronal survivalGuidance of regenerating axons via bands of BüngnerSecretion of neurotrophic factors (e.g., NGF, BDNF, GDNF, NT-3)Recruitment of immune cells (macrophages)Breakdown and clearance of myelin via autophagyInteraction with other cell types (fibroblasts, macrophages, adipocytes)
04

Disease associations

Neurodegenerative disease (especially peripheral nerve injury)Trauma-induced nerve damageDemyelinating neuropathies
05

Safety considerations

Slow regeneration (<1 mm/day in humans)[1]Loss of repair phenotype over time—chronic denervation reduces regenerative ability[1][3]Schwann cell apoptosis leading to deterioration of supportive structures (“bands of Büngner”)[1]Incomplete or aberrant repair in chronic injury (clinical challenge)
06

Biomarkers

c-Jun expression levelsUpregulation of neurotrophic factors (NGF, BDNF, GDNF)Downregulation of myelination proteins (P0, MBP)

Beyond the preview

Go deeper on Schwann cell repair phenotype.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schwann cell repair phenotype.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call